Last reviewed · How we verify

NCT04182542

Effects of Capacitive Radiofrequency at the Dermis and Adipose Tissue

Completed NA Last updated 4 September 2020
What this trial tests

NA trial testing Radiofrequency in Adiposity in 20 participants. Completed in 31 July 2020.

Timeline
2 December 2019
Primary endpoint
24 April 2020
31 July 2020

Quick facts

Lead sponsorEscola Superior de Tecnologia da Saúde do Porto
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingsingle
Primary purposetreatment
Enrollment20
Start date2 December 2019
Primary completion24 April 2020
Estimated completion31 July 2020
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Escola Superior de Tecnologia da Saúde do Porto

Who can join

18 and older, female only, with Adiposity or Abdominal Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Noninvasive fat reduction is a rapidly expanding field of cosmetic rejuvenation, as many patients are unwilling to suffer the downtime and healing associated with traditional invasive liposuction. The radiofrequency (RF) device has been shown to be safe and effective for non-invasive fat reduction, as well as cutaneous enhancement and improvement of skin flaccidity (BOISNIC, et al., 2014).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of capacitive radiofrequency on the dermis of the abdominal region.
    Monaretti GL, Costa MCF, Rocha LB, Cintra MMM, et al · · 2022 · cited 3× · PMID 33860864 · DOI 10.1007/s10103-021-03311-3

Verify or expand the search:

Other trials of Radiofrequency

Trials testing the same drug.

Other recruiting trials for Adiposity

Currently open trials in the same condition.

Other Escola Superior de Tecnologia da Saúde do Porto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04182542.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing